Modified Oral Metronidazole Desensitization Protocol
نویسندگان
چکیده
منابع مشابه
Modified oral metronidazole desensitization protocol
The Center for Disease Control guidelines recommend desensitization to metronidazole in patients with trichomoniasis and hypersensitivity to metronidazole. There is only one published oral metronidazole desensitization protocol. The purpose of this study was to design a new, more gradual oral desensitization protocol to decrease systemic reactions that may occur when using the previously publis...
متن کاملA modified, prolonged desensitization protocol in carboplatin allergy.
Carboplatin (CP) is the mainstay therapy in ovarian and testicular carcinoma. Several cases of allergic reactions to CP have been descr ibed? -3 Pre t rea tment with steroids and antihistamines did not prevent recurrent reactions. 1,3 A successful 4-hour desensitization protocol was documen ted in a single pa t i en t? We describe two patients allergic to CP who had recurrent reactions while un...
متن کامل394 Desensitization Protocol to Methotrexate
day. Conclusions: Symptomes and appearence of the disease suggested several diseases but the laboratory tests were normal, making the diagnosis more difficult, the supposed diagnosis did not fit properly for the patient age. Careful observation of patients and the disease, exfoliative cytology and a biopsy, microbiological investigations allow the diagnosis, ruling out erythema multiforme and d...
متن کاملA desensitization protocol to ganciclovir
Case report Hospitalized HIV-infected woman, 49 years-old, with AIDS, presenting with an active cytomegalovirus (CMV) gastrointestinal infection. On the second day of therapy with intravenous ganciclovir (250 mg, q12h), the patient developed an isolated pruriginous maculopapular exanthema localized to the torso and limbs. A hypersensitivity reaction to ganciclovir was suspected; by this time, a...
متن کاملInfusion-related reactions to Rituximab: pathogenic mechanism and proposal of a new modified desensitization protocol
Background Rituximab is a chimeric monoclonal antibody against the surface protein CD20 of B cells, used in the treatment of hematologic malignances and autoimmune diseases. Some patients develop hypersensitivity reactions after the infusion. It is unknown the percentage of these which are due to an IgE allergic mechanism. Also, there is not a standardized desensitization protocol that allows u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Allergy & Rhinology
سال: 2014
ISSN: 2152-6567,2152-6567
DOI: 10.2500/ar.2014.5.0080